
|Articles|May 3, 2021
ERT and Bioclinica Close Merger
Advertisement
ERT has announced
Joe Eazor is the CEO of the merged company, and the management team will be composed of a combination of both ERT and Bioclinica executives.
For more information, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Workforce Compression in AI-Driven Clinical Trial Operations
2
From Perspective to Action: Addressing the Real Cost Pressures in Clinical Trial Budgeting
3
Navigating the Adoption of Biomarker-Informed Trial Enrollment Beyond Oncology
4
ACT Brief: Site Cash Runway and Payment Infrastructure Priority, Biomarker Cut-Off Selection and Disparities, and Batch Failure Prevention Systems
5



